ASF1A and breast cancer: Our results show that ASF1A is aberrantly increased in CML-BC, which acts as a coactivator of the Notch transcriptional complex with RBPJ, to enhance Notch signaling activation, and subsequently induce differentiation arrest to drive the transformation to CML-BC.